$IBIO $MATN - penny stock - low hanging fruit. Both vaccine candidates of AIM and iBio need to go for Clinical Trial before it goes to FDA, but Matn has begun preparations to submit an Investigational New Drug Application (IND) to the Food and Drug Administration (FDA) for OT-101 against COVID-19 to expedite testing in COVID-19 patients. investor.mateon.com/news-re...
  • 4
  • 1